Takashi Kurihara Selected Research

Takashi Kurihara Research Topics

Disease

13	Hyperalgesia 12/2022 - 07/2002
9	Neuralgia (Stump Neuralgia) 01/2023 - 07/2002
8	Pain (Aches) 01/2023 - 07/2002
3	Infections 12/2023 - 11/2003
3	Inflammation (Inflammations) 01/2023 - 12/2003
2	Chronic Pain 01/2018 - 01/2017
2	Hypersensitivity (Allergy) 03/2014 - 12/2003
1	Lung Diseases (Lung Disease) 12/2023
1	COVID-19 12/2023
1	Asthma (Bronchial Asthma) 12/2023
1	Acute Lung Injury 12/2023
1	Peripheral Nerve Injuries 01/2023
1	Ischemic Stroke 01/2022
1	Cerebral Infarction 01/2022
1	Lung Injury 12/2021
1	Body Weight (Weight, Body) 04/2020
1	Cocaine-Related Disorders (Cocaine Addiction) 01/2018
1	Hemorrhagic Stroke 01/2014
1	Thalamic Diseases 01/2014
1	Intractable Pain 12/2004
1	Neoplasms (Cancer) 03/2003
1	Ganglion Cysts (Ganglion) 07/2002

Drug/Important Bio-Agent (IBA)

7	Analgesics (Analgesic Drugs)IBA 01/2023 - 12/2004
6	Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA 12/2022 - 01/2016
4	Type I Pituitary Adenylate Cyclase-Activating Polypeptide ReceptorsIBA 01/2020 - 01/2016
3	CarrageenanIBA 02/2015 - 12/2003
2	OzoneIBA 12/2023 - 12/2021
2	GW9508IBA 01/2023 - 02/2015
2	GW1100IBA 01/2023 - 01/2017
2	Formaldehyde (Formol)FDA Link 02/2019 - 03/2003
2	insect maxadilan proteinIBA 01/2018 - 01/2016
2	Nonesterified Fatty Acids (NEFA)IBA 01/2017 - 02/2015
2	Morphine (MS Contin)FDA LinkGeneric 01/2014 - 12/2004
2	Messenger RNA (mRNA)IBA 12/2009 - 11/2005
1	CytokinesIBA 12/2023
1	Imipramine (Janimine)FDA LinkGeneric 01/2023
1	Rose BengalIBA 01/2022
1	Coloring Agents (Dyes)IBA 01/2022
1	Pituitary Adenylate Cyclase-Activating Polypeptide ReceptorsIBA 04/2020
1	N-acetylneuraminoyllactose sulfate ester (ANLS)IBA 01/2018
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2017
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2017
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2017
1	Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA 01/2016
1	Substance PIBA 01/2016
1	Glial Fibrillary Acidic ProteinIBA 01/2016
1	N-Methylaspartate (NMDA)IBA 01/2016
1	Calcitonin Gene-Related PeptideIBA 01/2016
1	Casein Kinase I (Casein Kinase 1)IBA 03/2014
1	Freund's AdjuvantIBA 03/2014
1	IC 261IBA 03/2014
1	TG 003IBA 03/2014
1	Diclofenac (SR 38)FDA LinkGeneric 01/2014
1	Minocycline (Cyclops)FDA LinkGeneric 01/2014
1	Pregabalin (Lyrica)FDA Link 01/2014
1	Collagenases (Collagenase)FDA Link 01/2014
1	Casein Kinase 1 epsilonIBA 12/2009
1	Casein Kinases (Casein Kinase)IBA 12/2009
1	Complementary DNA (cDNA)IBA 12/2009
1	PK 11195 (PK11195)IBA 05/2009
1	GABA-A Receptors (GABA(A) Receptor)IBA 05/2009
1	Progesterone Receptors (Progesterone Receptor)IBA 07/2006
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 11/2005
1	dexamethasone 21-methanesulfonateIBA 11/2005
1	omega-Conotoxin GVIAIBA 12/2003
1	omega-Agatoxin IVAIBA 12/2003
1	ProstaglandinsIBA 12/2003
1	PlasticsIBA 12/2003
1	Dinoprostone (PGE2)FDA Link 12/2003
1	GlycosyltransferasesIBA 11/2003
1	FucosyltransferasesIBA 11/2003
1	EpitopesIBA 11/2003
1	SialyltransferasesIBA 11/2003
1	beta-1,4-mannosyl-glycoprotein beta-1,4-N-acetylglucosaminyltransferaseIBA 11/2003
1	Complement System Proteins (Complement)IBA 03/2003
1	Acetic Acid (Vinegar)FDA LinkGeneric 03/2003
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 07/2002
1	Ion Channels (Ion Channel)IBA 07/2002
1	Gabapentin (Neurontin)FDA LinkGeneric 07/2002

Therapy/Procedure

4	Spinal Injections 01/2020 - 03/2014
2	Ligation 03/2022 - 01/2020
1	Intravenous Injections 01/2022
1	Therapeutics 01/2014